{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:35:07Z","timestamp":1746322507465,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T00:00:00Z","timestamp":1633478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T00:00:00Z","timestamp":1633478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s13730-021-00652-4","type":"journal-article","created":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T18:04:11Z","timestamp":1633543451000},"page":"191-195","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Gitelman syndrome with a novel frameshift variant in SLC12A3 gene accompanied by chronic kidney disease and type 2 diabetes mellitus"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3885-1279","authenticated-orcid":false,"given":"Kenichiro","family":"Iio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayasu","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saki","family":"Bessho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Hatanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Omori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhiko","family":"Kouhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoko","family":"Chiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisei","family":"Sohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Ya","family":"Kaimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,6]]},"reference":[{"key":"652_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.kint.2016.09.046","volume":"91","author":"A Blanchard","year":"2017","unstructured":"Blanchard A, Bockenhauer D, Bolignano D, Cal\u00f2 LA, Cosyns E, Devuyst O, et al. Gitelman syndrome: consensus and guidance from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2017;91:24\u201333.","journal-title":"Kidney Int"},{"key":"652_CR2","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/humu.24159","volume":"42","author":"T Mori","year":"2021","unstructured":"Mori T, Chiga M, Fujimaru T, Kawamoto R, Mandai S, Nanamatsu A, et al. Phenotypic differences of mutation-negative cases in Gitelman syndrome clinically diagnosed in adulthood. Hum Mutat. 2021;42:300\u20139.","journal-title":"Hum Mutat"},{"key":"652_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10157-016-1252-1","volume":"21","author":"T Mori","year":"2017","unstructured":"Mori T, Hosomichi K, Chiga M, Mandai S, Nakaoka H, Sohara E, et al. Comprehensive genetic testing approach for major inherited kidney diseases, using next-generation sequencing with a custom panel. Clin Exp Nephrol. 2017;21:63\u201375.","journal-title":"Clin Exp Nephrol"},{"key":"652_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"652_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3346\/jkms.2016.31.1.47","volume":"31","author":"JW Lee","year":"2016","unstructured":"Lee JW, Lee J, Heo NJ, Cheong HI, Han JS. Mutations in SLC12A3 and CLCNKB and their correlation with clinical phenotype in patients with Gitelman and Gitelman-like syndrome. J Korean Med Sci. 2016;31:47\u201354.","journal-title":"J Korean Med Sci"},{"key":"652_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/jhg.2016.129","volume":"62","author":"K Nozu","year":"2017","unstructured":"Nozu K, Nozu Y, Nakanishi K, Konomoto T, Horinouchi T, Shono A, et al. Cryptic exon activation in SLC12A3 in Gitelman syndrome. J Hum Genet. 2017;62:335\u20137.","journal-title":"J Hum Genet"},{"key":"652_CR7","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1681\/ASN.2010090907","volume":"22","author":"R Vargas-Poussou","year":"2011","unstructured":"Vargas-Poussou R, Dahan K, Kahila D, Venisse A, Riveira-Munoz E, Debaix H, et al. Spectrum of mutations in Gitelman syndrome. J Am Soc Nephrol. 2011;22:693\u2013703.","journal-title":"J Am Soc Nephrol"},{"key":"652_CR8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1242\/jcs.181008","volume":"129","author":"T Kurosaki","year":"2016","unstructured":"Kurosaki T, Maquat LE. Nonsense-mediated mRNA decay in humans at a glance. J Cell Sci. 2016;129:461\u20137.","journal-title":"J Cell Sci"},{"key":"652_CR9","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1002\/humu.21364","volume":"31","author":"SS Yang","year":"2010","unstructured":"Yang SS, Lo YF, Yu IS, Lin SW, Chang TH, Hsu YJ, et al. Generation and analysis of the thiazide-sensitive Na+-Cl\u2212 cotransporter (Ncc\/Slc12a3) Ser707X knockin mouse as a model of Gitelman syndrome. Hum Mut. 2010;31:1304\u201315.","journal-title":"Hum Mut"},{"key":"652_CR10","unstructured":"Ellard S, Baple EL, Berry I, Forrester N, Turnbull C, Owens M, et al. ACGS best practice guidelines for variant classification 2020: association for clinical genetics science (ACGS), 2020. Available at: https:\/\/www.acgs.uk.com\/quality\/best-practice-guidelines\/#VariantGuidelines."},{"key":"652_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/ejhg.2011.189","volume":"20","author":"B Glaudemans","year":"2012","unstructured":"Glaudemans B, Yntema HG, San-Cristobal P, Schoots J, Pfundt R, Kamsteeg EJ, et al. Novel NCC mutants and functional analysis in a new cohort of patients with Gitelman syndrome. Eur J Hum Genet. 2012;20:263\u201370.","journal-title":"Eur J Hum Genet"},{"key":"652_CR12","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/ndt\/gfs600","volume":"28","author":"MR Berry","year":"2013","unstructured":"Berry MR, Robinson C, Karet Frankl FE. Unexpected clinical sequelae of Gitelman syndrome: hypertension in adulthood is common and females have higher potassium requirements. Nephrol Dial Transplant. 2013;28:1533\u201342.","journal-title":"Nephrol Dial Transplant"},{"key":"652_CR13","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/ckj\/sfx118","volume":"11","author":"PR Walsh","year":"2018","unstructured":"Walsh PR, Tse Y, Ashton E, Iancu D, Jenkins L, Bienias M, et al. Clinical and diagnostic features of Bartter and Gitelman syndromes. Clin Kidney J. 2018;11:302\u20139.","journal-title":"Clin Kidney J"},{"key":"652_CR14","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1681\/ASN.2019010031","volume":"30","author":"A Blanchard","year":"2019","unstructured":"Blanchard A, Vallet M, Dubourg L, Hureaux M, Allard J, Haymann JP, et al. Resistance to insulin in patients with Gitelman syndrome and a subtle intermediate phenotype in heterozygous carriers: a cross-sectional study. J Am Soc Nephrol. 2019;30:1534\u201345.","journal-title":"J Am Soc Nephrol"},{"key":"652_CR15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12882-018-1083-2","volume":"19","author":"Q Chen","year":"2018","unstructured":"Chen Q, Wu Y, Zhao J, Jia Y, Wang W. A case of hypokalemia and proteinuria with a new mutation in the SLC12A3 gene. BMC Nephrol. 2018;19:275.","journal-title":"BMC Nephrol"},{"key":"652_CR16","doi-asserted-by":"publisher","first-page":"E1478","DOI":"10.1210\/jc.2012-1707","volume":"97","author":"MH Tseng","year":"2012","unstructured":"Tseng MH, Yang SS, Hsu YJ, Fang YW, Wu CJ, Tsai JD, et al. Genotype, phenotype, and follow-up in Taiwanese patients with salt-losing tubulopathy associated with SLC12A3 mutation. J Clin Endocrinol Metab. 2012;97:E1478\u201382.","journal-title":"J Clin Endocrinol Metab"},{"key":"652_CR17","doi-asserted-by":"crossref","unstructured":"Demoulin N, Aydin S, Cosyns JP, Dahan K, Cornet G, Auberger I, et al. Gitelman syndrome and glomerular proteinuria: a link between loss of sodium-chloride cotransporter and podocyte dysfunction? Nephrol Dial Transplant. 2014; 29 Suppl 4:iv117\u201320.","DOI":"10.1093\/ndt\/gfu075"},{"key":"652_CR18","doi-asserted-by":"crossref","unstructured":"He G, Gang X, Sun Z, Wang P, Wang G, Guo W. Type 2 diabetes mellitus caused by Gitelman syndrome-related hypokalemia: A case report. Medicine (Baltimore). 2020; 99:e21123.","DOI":"10.1097\/MD.0000000000021123"},{"key":"652_CR19","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000346708","volume":"37","author":"H Ren","year":"2013","unstructured":"Ren H, Qin L, Wang W, Ma J, Zhang W, Shen PY, et al. Abnormal glucose metabolism and insulin sensitivity in Chinese patients with Gitelman syndrome. Am J Nephrol. 2013;37:152\u20137.","journal-title":"Am J Nephrol"},{"key":"652_CR20","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.kint.2019.02.030","volume":"96","author":"J Barrera-Chimal","year":"2019","unstructured":"Barrera-Chimal J, Girerd S, Jaisser F. Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis. Kidney Int. 2019;96:302\u201319.","journal-title":"Kidney Int"},{"key":"652_CR21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.kint.2017.08.038","volume":"93","author":"PI Georgianos","year":"2018","unstructured":"Georgianos PI, Agarwal R. Revisiting RAAS blockade in CKD with newer potassium-binding drugs. Kidney Int. 2018;93:325\u201334.","journal-title":"Kidney Int"},{"key":"652_CR22","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1093\/qjmed\/hcr095","volume":"104","author":"SB Walsh","year":"2011","unstructured":"Walsh SB, Unwin E, Vargas-Poussou R, Houillier P, Unwin R. Does hypokalaemia cause nephropathy? An observational study of renal function in patients with Bartter or Gitelman syndrome. QJM. 2011;104:939\u201344.","journal-title":"QJM"},{"key":"652_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1161\/01.HYP.0000231552.10054.aa","volume":"48","author":"AJ Zillich","year":"2006","unstructured":"Zillich AJ, Garg J, Basu S, Bakris GL, Carter BL. Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension. 2006;48:219\u201324.","journal-title":"Hypertension"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-021-00652-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-021-00652-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-021-00652-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T11:29:38Z","timestamp":1725881378000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-021-00652-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,6]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["652"],"URL":"https:\/\/doi.org\/10.1007\/s13730-021-00652-4","relation":{},"ISSN":["2192-4449"],"issn-type":[{"type":"electronic","value":"2192-4449"}],"subject":[],"published":{"date-parts":[[2021,10,6]]},"assertion":[{"value":"27 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This article does not describe any studies with animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving Human Participants and\/or Animals"}}]}}